Skip to main content
Premium Trial:

Request an Annual Quote

OvaGene Opens Clinical, Research Lab

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – OvaGene Oncology today announced the opening of its new clinical and research laboratory in Irvine, Calif., where the company is headquartered.

The facility will serve as the central headquarter for operations, research, and molecular clinical lab testing, OvaGene said in a statement. Technologies used for genomic testing on cancer cells at the facility include qPCR, comparative genomic hybridization, and gene expression arrays.

OvaGene is in the process of pursuing clinical laboratory licensure and accreditation. If it is successful, the company will offer molecular diagnostics to the gynecological community, it said. In addition, the company will develop diagnostics based on in-licensed technologies and internal research. The research will include collaborations with pharma firms in the oncology space in order to develop companion diagnostics.

OvaGene develops and commercializes personalized DNA-based diagnostics for gynecologic cancer.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.